Canton Biologics Funding: $41M Raised, Series C (2023)

Canton Biologics funding overview

Canton Biologics is based in Guangzhou, China. Canton Biologics has raised $41M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in September 2023. The round record for Canton Biologics runs through 2023; nothing later has been disclosed. Investors on record include SDIC Venture Capital, Guangdong Technology Financial Group, Taipu Life Science Investment, Chnin Financial. 4 distinct backers are named across the disclosed rounds.

Canton Biologics at a glance

Total raised: $41M
Latest round: Series C
Latest round date: September 2023
Headquarters: Guangzhou, China
Notable investors: SDIC Venture Capital, Guangdong Technology Financial Group, Taipu Life Science Investment, Chnin Financial

Frequently asked about Canton Biologics funding

How much has Canton Biologics raised?: Canton Biologics has raised $41M in total disclosed funding across the rounds on record.
Who has invested in Canton Biologics?: SDIC Venture Capital, Guangdong Technology Financial Group, Taipu Life Science Investment, Chnin Financial are named among the investors backing Canton Biologics.
What was the latest Canton Biologics funding round?: The most recent disclosed round is a Series C, announced in September 2023.
Where is Canton Biologics based?: Canton Biologics is based in Guangzhou, China.
When did Canton Biologics last raise?: The last disclosed Canton Biologics round closed in September 2023 at Series C.

We update the Canton Biologics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Guangzhou and their backers are listed below.

Canton Biologics Funding: $41M Raised, Series C (2023)

Canton Biologics funding overview

Canton Biologics at a glance

Frequently asked about Canton Biologics funding

Companies related to Canton Biologics (26)

Browse related funding lists (4)